Port Erin Biopharma Investments Ltd Stock London S.E.
Equities
IM00B6QH1J21
Investment Management & Fund Operators
Sales 2022 | 6.42M 8.13M | Sales 2023 | 29.7M 37.58M | Capitalization | 104M 131M |
---|---|---|---|---|---|
Net income 2022 | 8M 10.12M | Net income 2023 | 22M 27.83M | EV / Sales 2022 | 1.58 x |
Net cash position 2022 | 146M 185M | Net cash position 2023 | 170M 215M | EV / Sales 2023 | -2.23 x |
P/E ratio 2022 |
17.6
x | P/E ratio 2023 |
4.73
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.97% |
Managers | Title | Age | Since |
---|---|---|---|
Denham Eke
DFI | Director of Finance/CFO | 73 | 12-05-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 11-05-02 |
Richard Reed
BRD | Director/Board Member | 51 | 19-05-30 |
David Giampaolo
BRD | Director/Board Member | 65 | 19-05-30 |
1st Jan change | Capi. | |
---|---|---|
+14.64% | 3.05B | |
+12.82% | 2.06B | |
+10.08% | 1.51B | |
-11.54% | 1.2B | |
+12.39% | 756M | |
+29.95% | 570M | |
-4.17% | 503M | |
+25.78% | 466M | |
+3.90% | 309M |